We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 771

Constitutional Court specifies requirements for privatisation of forensic mental health services
  • Freshfields Bruckhaus Deringer LLP
  • Germany
  • March 1 2012

The Federal Constitutional Court has recently ruled that the so-called 'Hessian Model of a formal privatisation of forensic mental health services is constitutional

Compensating employee inventors
  • Taylor Wessing
  • Austria, Germany, United Kingdom
  • January 30 2014

In the life sciences, highly qualified and skilled people are employed in the research and development of new drug candidates and other advancements

CJEU to provide guidance on the scope of the Bolar exemption
  • Dehns
  • European Union, Germany, Poland, United Kingdom
  • January 28 2014

Is the supply of patent-protected products to a generics company which intends to use the product in tests necessary to obtain marketing

Global intellectual property newsletter - issue 0115
  • Clifford Chance LLP
  • China, European Union, Germany, Poland, Spain, United Kingdom, USA
  • January 21 2015

Establishment of the Unified European Patent Litigation System has been subject to many efforts of European leaders and legislators for more than four

Justifying age discrimination
  • Reed Smith LLP
  • European Union, Germany
  • January 20 2010

The European Court of Justice (ECJ) has ruled that the protection of patients from declining performance of dentists due to their age may be a legitimate aim justifying difference in treatment on the grounds of age

Privacy Commissioner criticizes draft law on e-health
  • Squire Patton Boggs
  • Germany
  • February 9 2015

The Privacy Commissioner of Schleswig-Holstein recently criticized the draft law on e-health, published by the Federal Ministry of Health, for

World Obesity Federation conference to target Dietary Sugars and Metabolic Disease Risk
  • Shook Hardy & Bacon LLP
  • Germany
  • March 20 2015

The World Obesity Federation is convening clinicians, researchers and policymakers in Berlin, Germany, for a June 29-30, 2015, conference titled

  • SKW Schwarz Rechtsanwälte
  • Germany
  • February 13 2015

By law, a company can market a pharmaceutical product only once it has received marketing authorisation. Marketing authorisation can be obtained

New German law proposed regarding anti-corruption in the healthcare sector
  • Hogan Lovells
  • Germany
  • February 10 2015

The German Ministry of Justice recently provided a new draft anticorruption law explicitly referring to the healthcare sector. If adopted, this law

Infringement of second medical use patents
  • Taylor Wessing
  • Germany, United Kingdom
  • March 4 2015

With the increase in off-label prescribing in Europe, some argue that the carve-outs used by generic firms (see "Skinny labelling and the blue box